• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2300751 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) New Drug Application 2023-11-02 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd view
JYSB2400149 司美格鲁肽注射液 semaglutide Injection Biological Products Supplementary Application 2024-07-12 Novo Nordisk Pharma AG;Novo Nordisk A/S view
CXSL2300279 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) New Drug Application 2023-04-20 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
JYSB2500016 司美格鲁肽注射液 semaglutide Injection Biological Products Supplementary Application 2025-01-10 Novo Nordisk A/S view
CXSS2400033 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) New Drug Application 2024-04-03 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd view
CXHL2400920 司美格鲁肽注射液 semaglutide Injection Chemical Drugs(2.2) New Drug Application 2024-09-07 China Resources Double-Crane Pharmaceutical Co Ltd view
JYSB2101164 司美格鲁肽注射液 semaglutide Injection Biological Products(3.1) Supplementary Application 2021-11-11 Novo Nordisk Pharma AG;Novo Nordisk A/S view
CXSL2400818 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) New Drug Application 2024-12-04 Shandong New Time Pharmaceutical Co Ltd view
CXHL2400795 司美格鲁肽注射液 semaglutide Injection Chemical Drugs(2.2) New Drug Application 2024-08-09 Yichang Humanwell Pharmaceutical Co Ltd view
JTS2400141 司美格鲁肽注射液 semaglutide Injection Biological Products Disposable Import Drug Application 2024-10-30 Hybio Pharmaceutical Co Ltd;Novo Nordisk A/S view
CXSL2300819 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) New Drug Application 2023-11-28 Chengdu Beite Biopharmaceutical Co Ltd view
JTS2400054 司美格鲁肽注射液 semaglutide Injection Biological Products Disposable Import Drug Application 2024-07-18 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Novo Nordisk A/S view
CXHL2401075 司美格鲁肽注射液 semaglutide Injection Chemical Drugs(2.2) New Drug Application 2024-10-15 Zhejiang Apeloa Kangyu Pharmaceutical Co Ltd view
CXHL2300646 司美格鲁肽注射液 semaglutide Injection Chemical Drugs(2.2) New Drug Application 2023-06-15 Beijing Kangchuanglian Biopharmaceutical Technology Research Co Ltd;CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd view
JXSS2500009 司美格鲁肽注射液 semaglutide Injection Biological Products(3.1) Import Drug Application 2025-02-12 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSB2400046 司美格鲁肽注射液 semaglutide Injection Biological Products(3.3) Supplementary Application 2024-05-21 Chengdu Beite Biopharmaceutical Co Ltd view
JTS2400094 司美格鲁肽注射液 semaglutide Injection Biological Products Disposable Import Drug Application 2024-09-21 Chengdu Beite Biopharmaceutical Co Ltd;Novo Nordisk A/S view
CXHL2200325 司美格鲁肽注射液 semaglutide Injection Chemical Drugs(2.2) New Drug Application 2022-05-25 QILU Pharmaceutical Co Ltd view
JTS2400163 司美格鲁肽注射液 semaglutide Injection Biological Products Disposable Import Drug Application 2024-12-12 Beijing Novotel Biotechnology Co Ltd;Novo Nordisk A/S view
JTS2400081 司美格鲁肽注射液 semaglutide Injection Biological Products Disposable Import Drug Application 2024-08-21 Chengdu Beite Biopharmaceutical Co Ltd;Novo Nordisk A/S view